BTG3 and rheumatoid arthritis: The reported ANA positivity rates in RA range from 14% to 77%, with major differences likely arising from population characteristics (e.g., ethnicity, disease duration) and concomitant treatments, rather than detection methods, as all studies utilized HEp-2 cell-based IIF ANA testing.